These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19796574)

  • 1. Angiogenic study in Graves' disease treated with thyroid arterial embolization.
    Zhao W; Gao BL; Liu ZY; Yi GF; Shen LJ; Yang HY; Li H; Song DP; Jiang YN; Hu JH; Luo G
    Clin Invest Med; 2009 Oct; 32(5):E335-44. PubMed ID: 19796574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graves' disease treated with thyroid arterial embolization.
    Zhao W; Gao BL; Tian M; Yi GF; Yang HY; Shen LJ; Li H; Shen J
    Clin Invest Med; 2009 Apr; 32(2):E158-65. PubMed ID: 19331805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptotic study in Graves disease treated with thyroid arterial embolization.
    Zhao W; Gao BL; Yi GF; Jin CZ; Yang HY; Shen LJ; Tian M; Yu YZ; Li H; Song DP
    Endocr J; 2009; 56(2):201-11. PubMed ID: 19008632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term immunological study in Graves' disease treated with thyroid arterial embolization.
    Zhao W; Gao BL; Jin CZ; Yi GF; Yang HY; Li H; Song DP; Hu JH; Jiang YN
    J Clin Immunol; 2008 Sep; 28(5):456-63. PubMed ID: 18633697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid arterial embolization to treat Graves' disease.
    Zhao W; Gao BL; Yang HY; Li H; Song DP; Xiang ST; Shen J
    Acta Radiol; 2007 Mar; 48(2):186-92. PubMed ID: 17354140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial embolization: a novel approach to thyroid ablative therapy for Graves' disease.
    Xiao H; Zhuang W; Wang S; Yu B; Chen G; Zhou M; Wong NC
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3583-9. PubMed ID: 12161479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay.
    Maugendre D; Massart C
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):89-96. PubMed ID: 11167931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of peritoneal dialysis on expression of vascular endothelial growth factor, basic fibroblast growth factor and endostatin of the peritoneum in peritoneal dialysis patients.
    Gao D; Zhao ZZ; Liang XH; Li Y; Cao Y; Liu ZS
    Nephrology (Carlton); 2011 Nov; 16(8):736-42. PubMed ID: 21771176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor (VEGF), VEGF receptors expression and microvascular density in benign and malignant thyroid diseases.
    Jebreel A; England J; Bedford K; Murphy J; Karsai L; Atkin S
    Int J Exp Pathol; 2007 Aug; 88(4):271-7. PubMed ID: 17696908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF and bFGF expression and microvessel density of maxillary sinus squamous cell carcinoma in relation to p53 status, spontaneous apoptosis and prognosis.
    Bandoh N; Hayashi T; Takahara M; Kishibe K; Ogino T; Katayama A; Imada M; Nonaka S; Harabuchi Y
    Cancer Lett; 2004 May; 208(2):215-25. PubMed ID: 15142681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Observation on therapeutic effect of picking therapy on Graves' disease].
    Li GL; Zhou ZX; Li JM
    Zhongguo Zhen Jiu; 2006 Nov; 26(11):769-71. PubMed ID: 17165495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' disease.
    Nagasaki T; Inaba M; Kumeda Y; Fujiwara-Ueda M; Hiura Y; Nishizawa Y
    Biomed Pharmacother; 2007 Sep; 61(8):472-6. PubMed ID: 17420111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exacerbation of thyroid associated ophthalmopathy after arterial embolization therapy in a patient with Graves' disease.
    Hiraiwa T; Imagawa A; Yamamoto K; Arimoto H; Arishima T; Ito M; Nakamura Y; Matsuzuka F; Miyauchi A; Sugasawa J; Ikeda T; Narumi Y; Hanafusa T
    Endocrine; 2009 Jun; 35(3):302-5. PubMed ID: 19381887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
    Chen W; Man N; Li YS; Shan ZY; Teng WP
    Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The calcium-phosphate balance, modulation of thyroid autoimmune processes and other adverse effects connected with thyroid arterial embolization.
    Kaminski G; Jaroszuk A; Zybek A; Brzozowski K; Piasecki P; Ziecina P; Ruchala M
    Endocrine; 2014 Jun; 46(2):292-9. PubMed ID: 24146411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum vascular endothelial growth factor levels and intrathyroidal vascular area in patients with Graves' disease and Hashimoto's thyroiditis.
    Iitaka M; Miura S; Yamanaka K; Kawasaki S; Kitahama S; Kawakami Y; Kakinuma S; Oosuga I; Wada S; Katayama S
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3908-12. PubMed ID: 9814467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous assay for three types of thyrotropin receptor antibody activities using FRTL-5 cells in patients with autoimmune thyroid diseases.
    Zhu Y; Portmann L; Dénéréaz N; Lemarchand-Béraud T
    Eur J Endocrinol; 1994 Oct; 131(4):359-68. PubMed ID: 7921224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease.
    Kashiwai T; Tada H; Watanabe Y; Shimaoka Y; Yagoro A; Hidaka Y; Fujikado T; Amino N
    Thyroid; 1998 Oct; 8(10):881-5. PubMed ID: 9827654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological findings and thyroid function of untreated Graves' disease patients with undetectable TSH-binding inhibitor immunoglobulin.
    Mukuta T; Tamai H; Oshima A; Morita T; Matsubayashi S; Fukata S; Kuma K
    Clin Endocrinol (Oxf); 1994 Feb; 40(2):215-9. PubMed ID: 7907955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.